doi: 10.4997/jrcpe.2009.425.
Statins: in the beginning
Affiliations
- PMID: 20509462
- DOI: 10.4997/jrcpe.2009.425
Item in Clipboard
Statins: in the beginning
J R Coll Physicians Edinb.
2009 Dec.
Abstract
Since the first human trial of a hydroxymethylglutaryl-coenzyme A (HMG CoA) reductase inhibitor in 1978, the growth in importance of this drug class, both financially and medically, has been staggering. The aim of this paper is to summarise how this drug class was developed, highlighting the role ofAkira Endo.
Similar articles
-
Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.Atheroscler Suppl. 2004 Oct;5(3):51-5. doi: 10.1016/j.atherosclerosissup.2004.08.023. Atheroscler Suppl. 2004. PMID: 15531275 No abstract available.
-
Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.Atheroscler Suppl. 2004 Oct;5(3):39-42. doi: 10.1016/j.atherosclerosissup.2004.08.021. Atheroscler Suppl. 2004. PMID: 15531273 No abstract available.
-
Lowering plasma cholesterol by raising ldl receptors. 1981.Atheroscler Suppl. 2004 Oct;5(3):57-9. doi: 10.1016/j.atherosclerosissup.2004.08.024. Atheroscler Suppl. 2004. PMID: 15531276 No abstract available.
-
The discovery and development of HMG-CoA reductase inhibitors.J Lipid Res. 1992 Nov;33(11):1569-82. J Lipid Res. 1992. PMID: 1464741 Review. No abstract available.
-
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005. Clin Pharmacokinet. 1997. PMID: 9160173 Review.
Cited by
-
Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women.Pharmaceuticals (Basel). 2020 Nov 25;13(12):422. doi: 10.3390/ph13120422. Pharmaceuticals (Basel). 2020. PMID: 33255609 Free PMC article. Review.
-
Assessing the effect of high-dose rosuvastatin in elderly patients over 75 with acute coronary syndrome.BMC Cardiovasc Disord. 2024 Sep 6;24(1):474. doi: 10.1186/s12872-024-04142-0. BMC Cardiovasc Disord. 2024. PMID: 39243009 Free PMC article.
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
LinkOut - more resources
Full Text Sources
Medical